New Risk • Apr 30
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.0m free cash flow). Share price has been highly volatile over the past 3 months (18% average weekly change). Earnings have declined by 2.8% per year over the past 5 years. Shareholders have been substantially diluted in the past year (241% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (CA$1.88m market cap, or US$1.39m). New Risk • Apr 04
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.0m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.0m free cash flow). Earnings have declined by 2.8% per year over the past 5 years. Shareholders have been substantially diluted in the past year (241% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (CA$1.76m market cap, or US$1.26m). Minor Risk Share price has been volatile over the past 3 months (17% average weekly change). Aankondiging • Jan 21
Lexston Mining Corporation announced that it has received CAD 0.5 million in funding On January 20, 2026, Lexston Mining Corporation closed the transaction. New Risk • Jan 15
New major risk - Revenue and earnings growth Earnings have declined by 0.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (26% average weekly change). Earnings have declined by 0.2% per year over the past 5 years. Shareholders have been substantially diluted in the past year (284% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (CA$1.79m market cap, or US$1.29m). Aankondiging • Dec 25
Lexston Mining Corporation announced that it expects to receive CAD 0.5 million in funding Lexston Mining Corporation announced a non brokered private placement to issue 6,250,000 units at a price of CAD 0.08 per unit for gross proceeds of CAD 500,000 on December 24, 2025. Each unit will consist of one common share and one common share purchase warrant. Each common share purchase warrant will entitle the holder to purchase one common share at a price of CAD 0.10 for five years from the date of issuance. Certain directors and officers of the Company may participate in the Private Placement. The securities to be issued in connection with the Private Placement are subject to the filing requirements with and acceptance by the Canadian Securities Exchange. All securities will be subject to a four-month statutory hold period after closing. New Risk • Oct 16
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$962k This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$962k free cash flow). Share price has been highly volatile over the past 3 months (27% average weekly change). Shareholders have been substantially diluted in the past year (208% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (CA$2.37m market cap, or US$1.68m). Aankondiging • Jul 22
Lexston Mining Corporation announced that it has received CAD 0.625235 million in funding On July 21, 2025, Lexston Mining Corporation closed the transaction. The company announced that the it has issued 6,766,586 common shares at a price of CAD 0.085 per share for gross proceeds of CAD 575,159.81 and 589,118 at an issue price of CAD 50,075.03; aggregate gross proceeds of CAD 625,234.84 of the total was issued as flow-through shares. All securities issued pursuant to the Private Placement are subject to a four-month statutory hold period until November 22, 2025. No finder’s fees were paid in relation to the Private Placement. Aankondiging • Jun 28
Lexston Mining Corporation announced that it expects to receive CAD 0.625175 million in funding Lexston Mining Corporation announced a private placement of up to 6,855,000 common shares at a price of CAD 0.085 per share for gross proceeds of up to CAD 582,675; and 500,000 flow-through common shares at a price of CAD 0.085 per share for gross proceeds of up to CAD 42,500; for aggregate gross proceeds of CAD 625,175 on June 27, 2025. The shares issued pursuant to the financing will be subject to the four months plus one day statutory hold period. The completion of the financing is subject to certain conditions including the receipt of all necessary approvals and the acceptance by the Canadian Securities Exchange. Aankondiging • Apr 30
Lexston Mining Corporation, Annual General Meeting, Jun 27, 2025 Lexston Mining Corporation, Annual General Meeting, Jun 27, 2025. New Risk • Apr 06
New major risk - Financial position The company has less than a year of cash runway based on its current free cash flow trend. Free cash flow: -CA$1.3m This is considered a major risk. With less than a year's worth of cash, the company will need to raise capital or take on debt unless its cash flows improve. This would dilute existing shareholders or increase balance sheet risk. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$1.3m free cash flow). Share price has been highly volatile over the past 3 months (75% average weekly change). Shareholders have been substantially diluted in the past year (121% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (CA$1.99m market cap, or US$1.40m). Aankondiging • Feb 19
Lexston Mining Corporation announced that it has received CAD 0.196 million in funding On February 18, 2025, Lexston Mining Corporation closed the transaction. All securities issued pursuant to the Private Placement are subject to a four-month statutory hold period until June 19, 2025. Aankondiging • Feb 06
Lexston Mining Corporation announced that it expects to receive CAD 0.196 million in funding Lexston Mining Corporation announced a non-brokered private placement to issue 2,450,000 units at issue price of CAD 0.08 per unit for gross proceeds of CAD 196,000 on February 4, 2025. Each unit will consist of one common share and one common share purchase warrant. Each common share purchase warrant will entitle the holder to purchase one common share at a price of CAD 0.10 for five years from the date of issuance. Certain directors and officers of the Company may participate in the Private Placement. The securities to be issued in connection with the Private Placement are subject to the Company’s filing requirements with the Canadian Securities Exchange. All securities will be subject to a four-month statutory hold period after closing. Aankondiging • Nov 04
Lexston Mining Corporation, Annual General Meeting, Dec 30, 2024 Lexston Mining Corporation, Annual General Meeting, Dec 30, 2024. Aankondiging • Oct 17
Lexston Mining Corporation Provides Project Update on the ITZA and 176 Uranium Properties in Nunavut Lexston Mining Corporation provided a project update on the ITZA and 176 Nunavut Uranium properties in Nunavut (the ‘Project’). Aurora Geoscience geologists completed 7 days of prospecting, mapping and sampling with helicopter access to the Project based out of Baker Lake. The work was completed with two crew, daily field traverses resulted in 75km of prospecting. 5 Areas were prospected and mapped utilizing a RS-125 scin- tillometer, a total of 113 boulders and 16 outcrops were surveyed. A total of 21 samples were collected and have been submitted to ALS laboratories for Geochemical Analysis - these results are still pending. Aurora geologists also provided field-based mapping outlining the extent of untill Veneer and Glaciofluvial deposits which cover >90% of the mapped areas. Preliminary Results: The recent field reconnaissance program yielded promising results, identifying several key indicators fa- vorable for uranium mineralization. Notably, low-level anomalous readings were detected over a broad area of boulder trains and outcrops using a handheld scintillometer, highlighting potential mineralization zones. Most of the prospective areas (approximately 90-95%) are covered by a thin veneer of glacial untill and glaciofluvial deposits, which is consistent with regional patterns and suggests that a potential deposit may be concealed beneath this cover. Encouraging signs of a broader mineralized system were observed, including strong hematite alteration and with promoted scintillometer readings. These findings, along with historical data, point to the 176- target area as particularly promising, though the central area also shows positive equal signs. Additionally, historical board spaced geophysics and regional geological mapping have identified signifi- cant structural lineaments in the area, intersecting with the unconformity associated with Thelon Basin sandstones. Basement structures known to host uranium-rich hydrothermal convection are present, and the proximity to the unconformity suggests that potential uranium mineralization could be relatively shal- low. Local geophysical anomalies align with the detected low-level uranium anomalism. Given the overlying untill veneer, further geophysical investigations are expected to refine understanding of the structural lin- eaments and better define the location of the unconformity within the identified anomalous zones. New Risk • Oct 06
New major risk - Shareholder dilution The company's shareholders have been substantially diluted in the past year. Increase in shares outstanding: 56% This is considered a major risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$523k free cash flow). Share price has been highly volatile over the past 3 months (24% average weekly change). Shareholders have been substantially diluted in the past year (56% increase in shares outstanding). Revenue is less than US$1m. Market cap is less than US$10m (CA$3.79m market cap, or US$2.79m). New Risk • Aug 30
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Canadian stocks, typically moving 18% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (18% average weekly change). Revenue has declined by 100% over the past year. Revenue is less than US$1m. Market cap is less than US$10m (CA$2.69m market cap, or US$2.00m). Minor Risk Shareholders have been diluted in the past year (48% increase in shares outstanding). Aankondiging • May 16
Lexston Mining Corporation announced that it has received CAD 0.41996 million in funding On May 15, 2024, Lexston Mining Corporation closed the transaction. The company issued 6,999,333 units at a price of CAD 0.06 per unit for a gross proceeds CAD 419,959.98. The Private Placement was oversubscribed by CAD 19,960. The transaction included participation from Company’s directors Jagdip Bal, Clinton Sharples and Jatinder J. Manhas participated in in the Private Placement and purchased a total of 1,973,334 units. The Company paid finder’s fee consisting of 8% cash and 8% broker warrants from raised proceeds and CAD 3,840 cash and 64,000 broker warrants to Haywood Securities Inc., CAD 5,997 cash and 93,280 broker warrants to Raymond James Ltd, and CAD 1,200 cash and 20,000 broker warrants to SCP Resources Finance LP. All securities issued pursuant to the Private Placement are subject to a four-month statutory hold period until September 16, 2024. Each common share purchase warrant entitles the holder to purchase one common share at a price of CAD 0.08 for two years from the date of issuance and will expire on May 15, 2026. New Risk • Apr 28
New minor risk - Insider selling There has been significant insider selling in the company's shares over the past 3 months. Total value of shares sold: CA$68k This is considered a minor risk. There are several reasons why an insider may be selling, including to cover a tax obligation or pay for some other expense. However, we generally consider it a negative if insiders have been selling, especially if they do so below the current price. It implies that they considered a lower price to be reasonable. This is a weak signal, but if there is a pattern of unexplained selling, it can be a sign the insider believes the company's stock is overpriced. Note: We only include open market transactions and private dispositions of directly owned stock by individuals, not by corporations or trusts. Currently, the following risks have been identified for the company: Major Risks Less than 1 year of cash runway based on free cash flow trend (-CA$488k free cash flow). Share price has been highly volatile over the past 3 months (33% average weekly change). Revenue has declined by 100% over the past year. Revenue is less than US$1m. Market cap is less than US$10m (CA$4.02m market cap, or US$2.94m). Minor Risks Less than 3 years of financial data is available. Shareholders have been diluted in the past year (11% increase in shares outstanding). Significant insider selling over the past 3 months (CA$68k sold). Recent Insider Transactions • Apr 28
President recently sold CA$61k worth of stock On the 26th of April, Jagdip Bal sold around 1m shares on-market at roughly CA$0.06 per share. This transaction amounted to 91% of their direct individual holding at the time of the trade. This was the largest sale by an insider in the last 3 months. Jagdip has been a net seller over the last 12 months, reducing personal holdings by CA$68k. Aankondiging • Jan 24
Lexston Mining Corporation Arranges Staking of Additional Mineral Claims in Thelon Basin, Nunavut Lexston Mining Corporation announced that further to its news releases dated November 27, 2023 and January 10, 2024, the Company has arranged staking of five new mineral claims for prospective uranium exploration. These five mineral claims are in the Thelon Basin in Nunavut Territory and occupy an area of 5,688ha. The total land area held for exploration by Lexston through the new five claims and the previously announced Project 176 and Project Itza Option Agreement in the Thelon Basin is now 11,350 hectares. These mineral claims will now make project Itza and 176 contiguous and cover 14 additional radiometric anomalies along the northern unconformity in the Thelon Basin. The Company identifies the following advantages of newly staked mineral claims: STRONG land position in the up-and-coming Thelon Basin; Extensive historical data available to guide exploration planning; Historical high-grade uranium occurrences;. Previous exploration programs terminated without extensive drill testing; Thelon Basin is experiencing a staking rush, and these projects cover the historically most attractive areas; and Multiple projects that cover the spectrum from conceptual exploration targets to near-drill ready targets. Project 176 - 1708Ha /17km2. Boulders containing high grade uranium anomalies were discovered by previous explorers. Project 176. is in the Northeastern portion of the Thelon Basin - 176 is within the most prospective region of the Thelon Basin. Multiple coincident anomalies: Magnetic low, VLF Electromagnetic, Gravity Low, Radiometric, Uranium in Soil, Track-etch Anomalies. The combination of the anomalies defined historically provides prime ingredients for discovering a high-grade uranium deposit within the project area. Geophysical work in 2012 defined similar fault arrays in the 176 Project area but market conditions prevented detailed follow-up. Project 176 was previously owned but never explored by Nex Gen Energy. Proposed Work: Re-process geophysical data and evaluate with the new geological theory proposed by Jefferson et al (2013). Complete high-resolution VTEM to add resolution to the basement conductors and anomalies identified in 2012. Complete high-resolution Gravity surveys. Project Itza - 3955ha /39.6 km2. Project Itza is located in the Northeastern portion of Thelon Basin - Itza was identified before the staking rush took place and is within the most prospective region the Thelon Basin that contains the high-grade uranium oxide samples. A boulder containing a uranium oxide anomaly sits within the project and planned drilling in 2007 was never completed. At least 3 radioactive boulder trains are located, and the source is yet to be tested. Project Itza sits at the mapped unconformity between the Thelon Formation and the underlying Amer Lake Metasediments. It contains reactivated Faults identified in 2013 - not identified when the properties were last explored (2012). The intersection of reactivated faults and unconformities is highly prospective for uranium deposits. e.g. Cigar Lake, Key Lake. Historical assessment reports show expenditures > $10m in the area, with at least $2m on the Itza Project. Multiple radioactive boulders were measured. Previous explorers (Titan and Mega) focused only on Amer Lake geology based on data acquired from previous operators, the potential for Neoarchean Rumble formation to underly part of the licence is high which presents a high-quality unconformity target. The project requires evaluation using concepts developed since exploration stopped in 2012. The project has yet to be explored since the 2007 geophysical surveys or the 2013 revised geological framework by Jefferson et al. The only drilling on the property was in 1980 and the aim then was to understand stratigraphy - not hunting for a deposit. No explorer has tested the Neoarchean rocks that are projected to underlie the project area. These rocks host the nearby Tatiggaq discovery and Kiggavik Deposit. The Company is a Canadian mineral exploration company, focused on the acquisition and development of mineral projects, with the objective to enhance value to all its stakeholders. Such factors include, among other things: risks and uncertainties relating to the acquisition of the common shares of the common shares of the Company, financings, the Company, financings. The Company, the Company, financing, the Company, the market valuing the Company in a manner not anticipated by management of the Company in a manner not expected by management of the Company in the market valuing the Company. The Company in a manner not anticipated to enhance value to enhance value to enhance value of the market valuing the company. Board Change • Oct 24
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 3 non-independent directors. Independent Director Richard Walker was the last independent director to join the board, commencing their role in 2023. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Sep 09
Lexston Life Sciences Corp., Annual General Meeting, Nov 08, 2023 Lexston Life Sciences Corp., Annual General Meeting, Nov 08, 2023. Board Change • Nov 16
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 3 non-independent directors. Director Clint Sharples was the last director to join the board, commencing their role in 2022. The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Oct 18
Lexston Life Sciences Corp. Announces Resignation of Graeme Staley as Director Lexston Life Sciences Corp. announced the resignation of Graeme Staley as a director of the Company effective October 14, 2022. Aankondiging • Sep 14
Lexston Life Sciences Corp. Appoints Clinton Sharples as A Director Lexston Life Sciences Corp. announced the appointment of Mr. Clinton Sharples as a director of the company. In addition, Mr. Sharples has joined the audit committee of the company. The audit committee now consists of Jagdip Bal, Graeme Staley and Clinton Sharples. Clinton Sharples is a partner in a private equity management company formed in 2005. His primary roles are CEO of Modu-Loc Fence Rentals and Chairman of Strategic Aviation and Sky Café. He is responsible for over 1,200 employees and $80 million in annual revenues. Mr. Sharples is also chairman of the board of Heritage Cannabis Holdings Corp. Board Change • Sep 12
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 2 non-independent directors. Independent Director Graeme Staley was the last independent director to join the board, commencing their role in 2021. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Sep 09
Lexston Life Sciences Corp. Announces Resignation of Harinder Bains as a Director Lexston Life Sciences Corp. announced the resignation of Harinder Bains as a director of the Company effective September 7, 2022. Aankondiging • Jul 05
Lexston Life Sciences Corp. announced that it has received CAD 0.928122 million in funding On July 4, 2022, Lexston Life Sciences Corp. closed the transaction. The company issued 18,562,440 units at a purchase price of CAD 0.05 per unit for gross proceeds of CAD 928,122 in the transaction. The Company has paid CAD 4,480 cash to Haywood Securities Inc and CAD 15,400 to Raymond James Ltd. and issued 89,600 broker’s warrants to Haywood Securities Inc. and 308,000 broker’s warrants to Raymond James Ltd. as finders’ fees. All securities issued pursuant to the Private Placement are subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation. Aankondiging • Jun 17
Lexston Life Sciences Corp. Announces the Resignation of Dr. Philippe Henry from His Positions as A Director and the Chief Science Officer of the Company Effective June 15, 2022 Lexston Life Sciences Corp. announced the resignation of Dr. Philippe Henry from his positions as a director and the Chief Science Officer of the Company effective June 15, 2022. Aankondiging • Jun 15
Lexston Life Sciences Corp., Annual General Meeting, Aug 11, 2022 Lexston Life Sciences Corp., Annual General Meeting, Aug 11, 2022. Aankondiging • Jun 02
Lexston Life Sciences Corp. announced that it expects to receive CAD 0.75 million in funding Lexston Life Sciences Corp. announced a non-brokered private placement consisting of up to 15,000,000 units at a purchase price of CAD 0.05 per unit to raise gross proceeds of up to CAD 750,000. Each unit will consist of one common share and one share purchase warrant. Each full warrant will entitle the holder to purchase one additional common share in the capital of the company for a period of five years, at a purchase price of CAD 0.075 per share. The company may pay a finder’s fee in connection with the transaction within the maximum amount permitted by the policies of the Canadian Securities Exchange and the applicable securities laws. Certain directors, officers and insiders of the company may participate in the transaction. The transaction is subject to several conditions, including receipt of all necessary corporate and regulatory approvals, including the exchange. All securities to be issued in connection with the private placement will be subject to a statutory hold period of four months plus a day from the date of issuance in accordance with applicable securities legislation. Board Change • Apr 27
No independent directors Following the recent departure of a director, there are no independent directors on the board. The company's board is composed of: No independent directors. 4 non-independent directors. was the last director to join the board, commencing their role in . The company's lack of independent directors is a risk according to the Simply Wall St Risk Model. Aankondiging • Apr 13
Lexston Life Sciences Corp., Annual General Meeting, Jun 17, 2022 Lexston Life Sciences Corp., Annual General Meeting, Jun 17, 2022. Aankondiging • Sep 25
Lexston Life Sciences Corp. Initiates Research and Development Project Using Psychedelic Compound 5-Me0-DMT Lexston Life Sciences Corp. announced that the company's scientific research and development division led by Chief Science Officer, Dr. Philippe Henry, has begun work on its tryptamine pipeline with an initial focus on 5-Methoxy-N, N-dimethyltryptamine (5-MeO-DMT) at its newly acquired Zenalytic Laboratories. With confirmation from Health Canada's Controlled Substances Directorate to proceed with characterization work on the target molecule, 5-MeO-DMT, the company's scientists have moved ahead with its plans to develop methods for the identification and quantification of this target tryptamine. The company has also successfully developed a High Pressure Liquid Chromatography (HPLC) assay for the determination and purity of 5-MeO-DMT, thus paving the way for future product development activities. Additionally, it has successfully collected Near-Infrared spectra (NIRs) from the purified substance to develop a portable rapid technique for the identification and quantification of tryptamine formulations at the point-of-care. the company is exploring different naturally derived botanical sources of 5-MeO-DMT, the use of different solvents and delivery systems for a formulation of a sub-psychoactive dosage. Based on its neuro-vasocontraction abilities this formulation will be used in conjunction with clinical partners specifically targeted for the alternative treatment of migraines and cluster headaches. In support of clinical applications, the Lexston team is also collecting serotonin and other receptor affinity data for 5-MeO-DMT, its metabolites and other closely related tryptamines. 5-MeO-DMT possesses unique pharmacodynamic and pharmacokinetic properties imparted by its specificity for serotonin receptors 5HT-1a,7,6,1d and dopamine D1. Unravelling the mechanism underlying the mode of action of this tryptamine is expected to shed light on potential novel treatments for major depressive disorders and addiction. Aankondiging • Sep 23
Lexston Life Sciences Corp. (CNSX:LEXT) acquired Zenalytic Laboratories Ltd. from Avant Brands Inc. (TSX:AVNT) for CAD 0.32 million. Lexston Life Sciences Corp. (CNSX:LEXT) acquired Zenalytic Laboratories Ltd. from Avant Brands Inc. (TSX:AVNT) for CAD 0.32 million on September 20, 2021. Lexston Life Sciences Corp. (CNSX:LEXT) paid CAD 50,000 in cash and issued 1,173,709 common shares of the Company to GreenTec Holdings Ltd., a wholly owned subsidiary of Avant Brands Inc. (TSX:AVNT).
Lexston Life Sciences Corp. (CNSX:LEXT) completed the acquisition of Zenalytic Laboratories Ltd. from Avant Brands Inc. (TSX:AVNT) for on September 20, 2021. Board Change • Jul 28
Less than half of directors are independent Following the recent departure of a director, there is only 1 independent director on the board. The company's board is composed of: 1 independent director. 4 non-independent directors. was the last director to join the board, commencing their role in . The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. 
